Navigation Links
Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop

/ II Trial of VELCADE and Perifosine (KRX-0401) in Relapsed / Refractory Multiple Myeloma Patients Previously Treated with VELCADE: Preliminary Results * Lead investigator: Paul Richardson, M.D., Dana-Farber Cancer Institute * Abstract #608; Poster session: Thursday 28th June, 4:30 p.m. -- Combination of the mTOR-Inhibitor Rapamycin and Proteasome Inhibitor VELCADE is Synergistic In Vitro in Multiple Myeloma * Lead investigator: Xavier Leleu, M.D., Centre Hospitalier Regional Universitaire de Lille * Abstract #534; Poster session: Tuesday 26th June, 4:30 p.m.

About Multiple Myeloma (MM)

Multiple myeloma is the second most common hematologic malignancy and although the disease is predominantly a cancer of the elderly (the average age of onset is 65 to 70 years of age), recent statistics indicate both increasing incidence and younger age of onset. In the U.S., more than 50,000 individuals have MM and close to 20,000 new cases are diagnosed each year. Worldwide there are approximately 74,000 new cases and more than 45,000 deaths annually.

About VELCADE

VELCADE is being co-developed by Millennium Pharmaceuticals, Inc. and Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Millennium is responsible for commercialization of VELCADE in the U.S.; Janssen-Cilag is responsible for commercialization in Europe and the rest of the world. Janssen Pharmaceutical K.K. is responsible for commercialization in Japan. For a limited period of time, Millennium and Ortho Biotech Inc. will co-promote VELCADE in the U.S. VELCADE is approved in more than 80 countries worldwide.

In the U.S., VELCADE is indicated for the treatment of patients with multiple myeloma who have received at least one prior therapy. VELCADE is indicated for the treatment of patients with mantle cell lymphoma who have received at least one prior therapy. VELCADE is c
'"/>




Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Velcade (bortezomib) for Injection Based Induction Therapy Delivered High Post-Transplant Complete Remission Rate, a Critical Marker for Increased Overall Survival
2. Velcade (Bortezomib) for Injection Based Therapies Produced Complete Remission Rates as High as 54 Percent in Patients With Previously Treated Multiple Myeloma
3. Velcade (bortezomib) for Injection Based Therapies Achieved Survival Rates as High as 100 Percent in Newly Diagnosed Multiple Myeloma Patients
4. Study Shows Velcade Plus Doxil Improves Survival in Previously Treated Patients With Multiple Myeloma
5. New Data on Market-Leading Velcade (Bortezomib) for Injection Further Strengthen Role in Previously Treated Multiple Myeloma
6. Millennium Discovers Biomarkers Potentially Predictive of Response to Velcade (Bortezomib) for Injection
7. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
8. Cytochroma Reports Positive Phase I Clinical Data for CTA018 Injection
9. Genta Announces Results of Phase 1 Study Using Genasense Administered by Intermittent Subcutaneous Injection
10. Aquavan (Fospropofol Disodium) Injection Data Presented at Digestive Disease Week 2007
11. Hana Biosciences Announces Data to be Presented On Talvesta (Talotrexin) for Injection at The American Association for Cancer Research Annual Meeting
Post Your Comments:
(Date:8/29/2014)... 2014   Mast Therapeutics, Inc. (NYSE ... that Santosh Vetticaden, Chief Medical Officer and Senior ... personal reasons, in mid-September.  Edwin L. Parsley ... Pharmaceuticals, which Mast acquired earlier this year, will ... interim Chief Medical Officer.  Dr. Parsley previously was ...
(Date:8/29/2014)... 2014 Research and Markets has ... Industry Report, 2014-2017" report to their offering. ... proportion of reimbursement for medical expenses, the Chinese orthopedic ... scale presenting a CAGR of 19.2% during 2009-2013. Trauma ... segments of orthopedic instruments in China ...
(Date:8/29/2014)... , Aug. 29, 2014 Does your doctor know ... 800 doctors have recommended marijuana to the over 112,000 currently ... But the majority of the other roughly 20,300+ active physicians ... very little about it – even though a poll in ... adults say they have tried it. "With ...
Breaking Medicine Technology:Mast Therapeutics Announces Management Change 2Mast Therapeutics Announces Management Change 3Mast Therapeutics Announces Management Change 4China Orthopedic Instrument Industry Report, 2014-2017 2Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 2Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 3Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 4
... 28 The U.S. Agency for International Development (USAID) ... in Addis Ababa, Ethiopia, in a regional exercise that ... Pandemic Preparedness initiative. The three-day exercise seeks to ... the event of a pandemic. As recently emphasized by ...
... As concerns over the spread of swine flu ... today that it is providing an additional $5 million ... American Health Organization (PAHO) in emergency support for efforts ... "Since 2005, USAID has committed $543 million to support ...
Cached Medicine Technology:USAID Cooperates in Pandemic Preparedness Initiative 2USAID Cooperates in Pandemic Preparedness Initiative 3USAID Provides $5M in Emergency Support as Swine Flu Spreads 2
(Date:8/31/2014)... 2014 This September, California Library ... Library, celebrates 30 years of changing the lives ... inception, California’s Library Literacy Services has helped nearly ... read and write. , To mark the 30th ... is launching a month-long awareness campaign titled “Together, ...
(Date:8/31/2014)... Rosa, CA (PRWEB) August 31, 2014 ... A healthcare provider specializing in menopause is ... address lifestyle expectations and relief from uncomfortable symptoms with ... same time complementary therapies offer a variety of alternative ... menopausal women. While these treatment options may fall outside ...
(Date:8/31/2014)... Drinking tea reduces non-cardiovascular mortality by 24%, reveals a ... today by Professor Nicolas Danchin from France. , Professor ... or coffee it,s probably better to drink tea. Coffee ... life. Their effects on cardiovascular (CV) health have been ... investigated the effects of coffee and tea on CV ...
(Date:8/30/2014)... August 2014: Local anaesthetic is as safe and effective ... according to results of the FRANCE 2 registry presented ... France. , Dr Chopard said: "Numerous studies have shown ... with severe symptomatic aortic stenosis who are at very ... replacement. The number of TAVI procedures in France and ...
(Date:8/30/2014)... Orlando, Florida (PRWEB) August 31, 2014 ... gait walking and how a mobility device can help in ... now available for free download from the website that contains ... medical doctor for this site. , The articles deal with ... mobility device like a walking cane can help in making ...
Breaking Medicine News(10 mins):Health News:California Library Literacy Services Celebrates 30th Anniversary 2Health News:California Library Literacy Services Celebrates 30th Anniversary 3Health News:A Look at Complementary Therapies and Alternative Medicine for National Menopause Awareness Month 2Health News:A Look at Complementary Therapies and Alternative Medicine for National Menopause Awareness Month 3Health News:A Look at Complementary Therapies and Alternative Medicine for National Menopause Awareness Month 4Health News:A Look at Complementary Therapies and Alternative Medicine for National Menopause Awareness Month 5Health News:Drinking tea reduces non-CV mortality by 24 percent 2Health News:Drinking tea reduces non-CV mortality by 24 percent 3Health News:Local anesthetic for TAVI as safe and effective as general anesthetic 2Health News:Information Articles on Gait Problems from Walking-Canes.Net 2
... woes cited in new research , , TUESDAY, March 18 (HealthDay ... bone health and post-traumatic stress disorder (PTSD), an explosion of ... gathered at a special news conference Tuesday. , The findings ... to certain illnesses than others -- and how they ...
... of only a few centers in Canada that perform living ... 1980s that expands the organ donor pool. About 80 liver ... being living-donor. , All potential liver transplant donors are assessed ... the liver and vascular and bile duct anatomy. Thanks to ...
... Includes Research From Around the World, Supports,Public Health ... service,containing thousands of scientific articles by African and ... announced the,Johns Hopkins Bloomberg School of Public Health ... service one of the largest of its kind., ...
... http://www.pharmacyfraudsettlement.com with filed documents, fraud, allegations, ... ... As front line professionals dispensing medications to,Medicaid beneficiaries pharmacists are particularly ... and report Medicaid fraud, which is noted in the site., ...
... VPN service to eight sites nationwide, - Triples network bandwidth to more ... ... solution, ROCHESTER, N.Y., March 18 Time ... and data,networking solutions for businesses, today announced a multi-year, contract,to deploy an ...
... Using fMRI scanning, researchers have found that the ... also accessed when inferring the thoughts of other people ... not the case when considering those who are different ... edition of the Proceedings of the National Academy of ...
Cached Medicine News:Health News:Genetic Medicine Making Inroads Against Disease 2Health News:Genetic Medicine Making Inroads Against Disease 3Health News:Resources Top 400,000 in Hopkins International Information Service 2Health News:CVS, America's Largest Pharmacy Chain, Pays Nearly $37 Million to Settle Federal and State Generic Drug Switching Charges 2Health News:CVS, America's Largest Pharmacy Chain, Pays Nearly $37 Million to Settle Federal and State Generic Drug Switching Charges 3Health News:CooperVision Increases Network Performance While Reducing Costs With Time Warner Telecom's IP VPN 2Health News:CooperVision Increases Network Performance While Reducing Costs With Time Warner Telecom's IP VPN 3Health News:Introspective experiences inform inferences about similar people -- but not dissimilar 2Health News:Introspective experiences inform inferences about similar people -- but not dissimilar 3
... prepare the skin for maximum adhesion of ... leave a thin film on the skin's ... a barrier for natural body oils that ... or tape and helps prevent skin irritation ...
... Triad Plus BZK ... Chloride solution and are ... Benzalkonium Chloride (BZK) may ... gentle cleansing solution is ...
BD Persist Plus protective barrier provides a one-step antimicrobial barrier with minimum of 1% chlorhexidine with Up to 7-day antimicrobial effectiveness....
... Triad Plus Sterile ... and 10% Acetone Swabsticks ... a topical antiseptic, anti-infective ... Acetone Alcohol provides an ...
Medicine Products: